Richard M. Keenan - Concepedia

Concepedia

Author

Richard M. Keenan

Also Known As

R Keenan, R M Keenan, R. Keenan, R. M. KEENAN, R. M. Keenan, Richard Keenan, Richard M Keenan, Richard M. Keenan

66

Publications

2.8K

Citations

30

H-Index

72

Concepts

All Affiliations

New Frontier South College GlaxoSmithKline (United States)Ligand Pharmaceuticals (United States)GlaxoSmithKline (United Kingdom)

RM

About

Richard M. Keenan is an author at New Frontier specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	33	2K
2	Biochemistry	16	18	1.1K
3	Natural Sciences	14	14	891
4	Engineering	1	1	19
5	Allergy	1	1	116

Richard M. Keenan

×

46

Publications

2.8K

Citations

30

H-Index

	Year	Citations
ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSURE Hans R. Brunner, Haralambos Gavras, John H. Laragh, The Lancet HypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular Pharmacology	1973	243
Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase Dashyant Dhanak, Kevin J. Duffy, Victor K. Johnston, Journal of Biological Chemistry	2002	196
3-(1,1-Dioxo-2<i>H</i>-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1<i>H</i>)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Rosanna Tedesco, Antony N. Shaw, Ramesh Bambal, Journal of Medicinal Chemistry	2006	159
Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase Dirk A. Heerding, Nelson Rhodes, Jack D. Leber, Journal of Medicinal Chemistry Cell DeathAkt KinaseMolecular PharmacologyMedicinal ChemistryReceptor Tyrosine Kinase	2008	154
1-(Carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists Joseph Weinstock, Richard M. Keenan, James M. Samanen, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyPharmaceutical ChemistryPre-clinical PharmacologyMolecular Pharmacology	1991	127
Hydrazinonaphthalene and Azonaphthalene Thrombopoietin Mimics Are Nonpeptidyl Promoters of Megakaryocytopoiesis Kevin J. Duffy, Michael G. Darcy, Evelyne Delorme, Journal of Medicinal Chemistry Drug TargetMolecular BiologyPharmacotherapyEpigeneticsMedicinal Chemistry	2001	119
Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic William H. Miller, Doreen Alberts, Pradip K. Bhatnagar, Journal of Medicinal Chemistry PharmacotherapyExperimental PharmacologyPharmacodynamic ModelingTranslational PharmacologyPre-clinical Pharmacology	1999	116
Discovery of Potent Nonpeptide Vitronectin Receptor (α<sub>V</sub>β<sub>3</sub>) Antagonists Richard M. Keenan, William H. Miller, Chet Kwon, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	1997	114
Identification and in vivo efficacy of small-molecule antagonists of integrin αvβ3 (the vitronectin receptor) William H. Miller, Richard M. Keenan, Robert N. Willette, Drug Discovery Today Vitronectin ReceptorIntegrin αVβ3MedicineImmunologyReceptor (Biochemistry)	2000	100
Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566. Richard M. Edwards, Nambi Aiyar, Eliot H. Ohlstein, PubMed HypertensionPharmacological CharacterizationCardiovascular PharmacologyPharmacotherapyCardiovascular Function	1992	96

Page 1